Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current problems of prostate cancer.

F Goncalves1, M Hornak, D Ondrus

  • 1Department of Urology, Faculty ofMedicine, Comenius University, Derer's Memorial Hospital, Bratislava, Slovakia. bll@fmed.uniba.sk

Bratislavske Lekarske Listy
|November 8, 2003
PubMed
Summary

Treating metastatic prostate cancer with complete androgen blockade offers no significant benefit over simpler methods. Hormone-refractory prostate cancer remains a difficult challenge due to limited standard therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surface hardening of a mould steel by laser quenching.

Scientific reports·2026
Same author

Do culturable seed endophyte communities differ between native and invasive Fabaceae sharing the same habitat?

Plant biology (Stuttgart, Germany)·2025
Same author

Cancer in the elderly in Slovakia.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Colorectal carcinoma - epidemiology, risk factors, prognostic bio markers.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Elexacaftor/tezacaftor/ivacaftor, a game-changer in cystic fibrosis: The Portuguese experience.

Pulmonary pharmacology & therapeutics·2024
Same author

Pancreatic cancer - epidemiology, risk factors, nutritional and infl ammatory prognostic and predictive factors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024

Area of Science:

  • Urology
  • Oncology
  • Endocrinology

Background:

  • Metastatic prostate cancer treatment relies heavily on endocrine manipulation.
  • Current strategies include luteinizing hormone-releasing hormone (LHRH) analogues, surgical castration, and antiandrogens.

Purpose of the Study:

  • To evaluate the efficacy of complete androgen blockade compared to standard endocrine therapies for metastatic prostate cancer.
  • To highlight the challenges in managing hormone-refractory prostate cancer.

Main Methods:

  • Review of existing treatment protocols for metastatic prostate cancer.
  • Comparative analysis of treatment outcomes for different endocrine manipulation strategies.

Main Results:

  • Complete androgen blockade, using LHRH analogues with antiandrogens or surgical castration with antiandrogens, did not demonstrate a significant advantage over LHRH analogues or surgical castration alone.

Related Experiment Videos

  • No definitive standard therapy exists for managing the progression to hormone-refractory prostate cancer.

    • Conclusions:

    • Simpler endocrine therapies are as effective as complete androgen blockade for metastatic prostate cancer.
    • The progression to hormone-refractory prostate cancer presents a significant unmet clinical need requiring further research and development of novel therapeutic approaches.